Documents
Application Sponsors
BLA 761044 | JANSSEN BIOTECH | |
Marketing Status
Application Products
001 | INJECTABLE;INJECTION | 130MG/26ML | 0 | STELARA | USTEKINUMAB |
FDA Submissions
TYPE 3; Type 3 - New Dosage Form | ORIG | 1 | AP | 2016-09-23 | STANDARD |
EFFICACY; Efficacy | SUPPL | 3 | AP | 2019-10-18 | STANDARD |
LABELING; Labeling | SUPPL | 5 | AP | 2020-04-07 | STANDARD |
LABELING; Labeling | SUPPL | 6 | AP | 2020-12-01 | STANDARD |
LABELING; Labeling | SUPPL | 8 | AP | 2020-12-11 | STANDARD |
LABELING; Labeling | SUPPL | 10 | AP | 2022-07-29 | STANDARD |
Submissions Property Types
ORIG | 1 | Null | 40 |
SUPPL | 3 | Null | 7 |
SUPPL | 6 | Null | 7 |
SUPPL | 8 | Null | 7 |
SUPPL | 10 | Null | 6 |
CDER Filings
JANSSEN BIOTECH
cder:Array
(
[0] => Array
(
[ApplNo] => 761044
[companyName] => JANSSEN BIOTECH
[docInserts] => ["Medication Guide","https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2020\/125261Orig1s153,761044s005lbl.pdf#page=39"]
[products] => [{"drugName":"STELARA","activeIngredients":"USTEKINUMAB","strength":"130MG\/26ML","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Prescription","te":"None","rld":"No","rs":"No"}]
[labels] => [{"actionDate":"04\/07\/2020","submission":"SUPPL-5","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2020\\\/125261Orig1s153,761044s005lbl.pdf\"}]","notes":""},{"actionDate":"11\/07\/2019","submission":"SUPPL-1","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2019\\\/125261s142,761044s001lbl.pdf\"}]","notes":""},{"actionDate":"10\/18\/2019","submission":"SUPPL-3","supplementCategories":"Efficacy-New Indication","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2019\\\/761044s003lbl.pdf\"}]","notes":""},{"actionDate":"09\/23\/2016","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2016\\\/761044lbl.pdf\"}]","notes":""}]
[originalApprovals] => [{"actionDate":"09\/23\/2016","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"N\/A","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2016\\\/761044lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2016\\\/761044Orig1s000ltr.pdf\"},{\"name\":\"Review\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/nda\\\/2016\\\/761044Orig1s000TOC.cfm\"}]","notes":">"}]
[supplements] => [{"actionDate":"04\/07\/2020","submission":"SUPPL-5","supplementCategories":"Supplement","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2020\\\/125261Orig1s153,761044s005lbl.pdf\"}]","notes":">"},{"actionDate":"10\/18\/2019","submission":"SUPPL-3","supplementCategories":"Supplement","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2019\\\/761044s003lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"\"}]","notes":">"},{"actionDate":"11\/07\/2019","submission":"SUPPL-1","supplementCategories":"Supplement","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2019\\\/125261s142,761044s001lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"\"}]","notes":">"}]
[actionDate] => 2020-04-07
)
)